Literature DB >> 17884987

Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation.

Dharmaraj Samuel1, Hong Cheng, Paul W Riley, Adrian A Canutescu, Chandrasekaran Nagaswami, John W Weisel, Zimei Bu, Peter N Walsh, Heinrich Roder.   

Abstract

Factor XI (FXI) is a homodimeric blood coagulation protein. Each monomer comprises four tandem apple-domain repeats (A1-A4) and a serine protease domain. We report here the NMR solution structure of the A4 domain (residues 272-361), which mediates formation of the disulfide-linked FXI dimer. A4 exhibits characteristic features of the plasminogen apple nematode domain family, including a five-stranded beta-sheet flanked by an alpha-helix on one side and a two-stranded beta-sheet on the other. In addition, the solution structure reveals a second alpha-helix at the C terminus. Comparison with a recent crystal structure of full-length FXI, combined with molecular modeling, suggests that the C-terminal helix is formed only upon proteolytic activation. The newly formed helix disrupts interdomain contacts and reorients the catalytic domains, bringing the active sites into close proximity. This hypothesis is supported by small-angle x-ray scattering and electron microscopy data, which indicate that FXI activation is accompanied by a major change in shape. The results are consistent with biochemical evidence that activated FXI cleaves its substrate at two positions without release of an intermediate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884987      PMCID: PMC1987390          DOI: 10.1073/pnas.0703080104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.

Authors:  M F Sun; M Zhao; D Gailani
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

Review 2.  Large-scale shape changes in proteins and macromolecular complexes.

Authors:  M E Wall; S C Gallagher; J Trewhella
Journal:  Annu Rev Phys Chem       Date:  2000       Impact factor: 12.703

Review 3.  Mechanisms of zymogen activation.

Authors:  R M Stroud; A A Kossiakoff; J L Chambers
Journal:  Annu Rev Biophys Bioeng       Date:  1977

4.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.

Authors:  R Asakai; D W Chung; O D Ratnoff; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains.

Authors:  B A McMullen; K Fujikawa; E W Davie
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

6.  Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein.

Authors:  K Fujikawa; D W Chung; L E Hendrickson; E W Davie
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

7.  Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX.

Authors:  D Sinha; F S Seaman; P N Walsh
Journal:  Biochemistry       Date:  1987-06-30       Impact factor: 3.162

8.  Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.

Authors:  D Sinha; A Koshy; F S Seaman; P N Walsh
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

9.  Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency.

Authors:  J C Meijers; E W Davie; D W Chung
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

10.  Domains of invasion organelle proteins from apicomplexan parasites are homologous with the Apple domains of blood coagulation factor XI and plasma pre-kallikrein and are members of the PAN module superfamily.

Authors:  P J Brown; A C Gill; P G Nugent; J H McVey; F M Tomley
Journal:  FEBS Lett       Date:  2001-05-18       Impact factor: 4.124

View more
  13 in total

1.  Productive recognition of factor IX by factor XIa exosites requires disulfide linkage between heavy and light chains of factor XIa.

Authors:  Mariola M Marcinkiewicz; Dipali Sinha; Peter N Walsh
Journal:  J Biol Chem       Date:  2011-12-29       Impact factor: 5.157

2.  Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.

Authors:  Wenman Wu; Dipali Sinha; Sergei Shikov; Calvin K Yip; Thomas Walz; Paul C Billings; James D Lear; Peter N Walsh
Journal:  J Biol Chem       Date:  2008-04-25       Impact factor: 5.157

Review 3.  Structure and function of factor XI.

Authors:  Jonas Emsley; Paul A McEwan; David Gailani
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

Review 4.  The mechanism underlying activation of factor IX by factor XIa.

Authors:  David Gailani; Yipeng Geng; Ingrid Verhamme; Mao-fu Sun; S Paul Bajaj; Amanda Messer; Jonas Emsley
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 5.  Update on the physiology and pathology of factor IX activation by factor XIa.

Authors:  Stephen B Smith; David Gailani
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

6.  A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.

Authors:  Tara N Miller; Dipali Sinha; T Regan Baird; Peter N Walsh
Journal:  Biochemistry       Date:  2007-11-17       Impact factor: 3.162

Review 7.  Structural and functional features of factor XI.

Authors:  D Gailani; S B Smith
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

8.  Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.

Authors:  Stephen B Smith; Ingrid M Verhamme; Mao-fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2008-01-11       Impact factor: 5.157

9.  The dimeric structure of factor XI and zymogen activation.

Authors:  Yipeng Geng; Ingrid M Verhamme; Stephen B Smith; Mao-Fu Sun; Anton Matafonov; Qiufang Cheng; Stephanie A Smith; James H Morrissey; David Gailani
Journal:  Blood       Date:  2013-03-20       Impact factor: 22.113

Review 10.  An update on factor XI structure and function.

Authors:  Bassem M Mohammed; Anton Matafonov; Ivan Ivanov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Chan Li; David Sun; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Thromb Res       Date:  2017-10-10       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.